Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 12:18 PM
Ignite Modification Date:
2025-12-25 @ 12:02 PM
NCT ID:
NCT04418661
Group ID:
EG005
Title:
Part 4- SAR442720 200mg + Pembrolizumab
Description:
Participants were administered SAR442720 200 mg orally BIW on Days 1 and 2 in 21-day cycles (as tablet during the first cycle and as capsule from Cycle 2) along with an IV infusion of pembrolizumab 200 mg Q3W (21-day cycle)or 400 mg Q6W (42-day cycle) until disease progression, unacceptable AEs, consent withdrawal, or the participant's or investigator's decision to stop the treatment.
Deaths Number Affected:
7
Deaths Number At Risk:
None
Serious Number Affected:
7
Serious Number At Risk:
15
Other Number Affected:
14
Other Number At Risk:
15
Study:
NCT04418661
Results Section:
NCT04418661
Adverse Events Module:
NCT04418661